Brief summary of biochemically recurrent prostate cancer, current imaging paradigms, and the unmet clinical need in PET/CT imaging.
A detailed summary of the Axumin clinical studies, including the rationale, study background, and clinical endpoints. Also includes a description of the products's mechanism of action (MOA).
Indication and ISI
Access to full Axumin Indication and Important Safety Information (ISI).
Dosing and Administration Guide
Contains detailed instructions for dosing and administration, including positioning patients, recommended timing for PET/CT imaging, and approximate timing for image acquisition.
Safety Data Sheet
Health and safety precautions for the preparation, handling, and use of Axumin.
Relevant product, procedure, and diagnosis coding information applicable for billing purposes.
Information to order Axumin for your facility and the list of services our sales representatives can provide.